Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
USS | Ann: Smartshares Limited - Change of Address | 07/10/24 | 0 | 18 | |||
|
|||||||
USS | Ann: USS NTA 04-10-2024 $7.23003 | 07/10/24 | 0 | 20 | |||
|
|||||||
USS | Ann: USS NTA 03-10-2024 $7.21036 | 04/10/24 | 0 | 35 | |||
|
|||||||
USS | Ann: USS NTA 02-10-2024 $7.17605 | 03/10/24 | 0 | 33 | |||
|
|||||||
USS | Ann: USS NTA 01-10-2024 $7.17064 | 02/10/24 | 0 | 37 | |||
|
|||||||
USS | Ann: USS NTA 30-09-2024 $7.16368 | 01/10/24 | 0 | 33 | |||
|
|||||||
USS | Ann: USS NTA 27-09-2024 $7.20951 | 30/09/24 | 0 | 37 | |||
|
|||||||
USS | Ann: USS NTA 26-09-2024 $7.15415 | 27/09/24 | 0 | 44 | |||
|
See All Discussions